antithrombin iii grifols 1000 ne por injekcióhoz
instituto grifols s.a. - antithrombin iii. -
antithrombin iii grifols 500 ne por injekcióhoz
instituto grifols s.a. - antithrombin iii. -
fanhdi 250 ne por és oldószer oldatos injekcióhoz
instituto grifols s.a. - a viii-as faktor, humán véralvadási -
fanhdi 1000 ne por és oldószer oldatos injekcióhoz
instituto grifols s.a. - a viii-as faktor, humán véralvadási -
flebogamma 5% 0,5 g oldatos infúzió
instituto grifols s.a. - immunglobulin (humán) -
flebogamma 5% 2,5 g oldatos infúzió
instituto grifols s.a. - immunglobulin (humán) -
flebogamma 5% 5 g oldatos infúzió
instituto grifols s.a. - immunglobulin (humán) -
flebogamma 5% 10 g oldatos infúzió
instituto grifols s.a. - immunglobulin (humán) -
fanhdi 500 ne por és oldószer oldatos injekcióhoz
instituto grifols s.a. - a viii-as faktor, humán véralvadási -
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - a humán normál immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunrendszer sera, immunglobulinok, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.